IGF1 and acromegaly: Univariate analysis showed that age <40 years, normal or overweight, baseline IGF-1 <300 μg/L or ranged between 300 and 500 μg/L, and all pegvisomant dose <20 mg/day were associated with a lower probability of acromegaly uncontrol.